Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
mTORC2 critically regulates renal potassium handling
Florian Grahammer, … , Ferruh Artunc, Tobias B. Huber
Florian Grahammer, … , Ferruh Artunc, Tobias B. Huber
Published April 4, 2016
Citation Information: J Clin Invest. 2016;126(5):1773-1782. https://doi.org/10.1172/JCI80304.
View: Text | PDF
Research Article Nephrology

mTORC2 critically regulates renal potassium handling

  • Text
  • PDF
Abstract

The mTOR pathway orchestrates cellular homeostasis. The rapamycin-sensitive mTOR complex (mTORC1) in the kidney has been widely studied; however, mTORC2 function in renal tubules is poorly characterized. Here, we generated mice lacking mTORC2 in the distal tubule (Rictorfl/fl Ksp-Cre mice), which were viable and had no obvious phenotype, except for a 2.5-fold increase in plasma aldosterone. Challenged with a low-Na+ diet, these mice adequately reduced Na+ excretion; however, Rictorfl/fl Ksp-Cre mice rapidly developed hyperkalemia on a high-K+ diet, despite a 10-fold increase in serum aldosterone levels, implying that mTORC2 regulates kaliuresis. Phosphorylation of serum- and glucocorticoid-inducible kinase 1 (SGK1) and PKC-α was absent in Rictorfl/fl Ksp-Cre mice, indicating a functional block in K+ secretion activation via ROMK channels. Indeed, patch-clamp experiments on split-open tubular segments from the transition zone of the late connecting tubule and early cortical collecting duct demonstrated that Ba2+-sensitive apical K+ currents were barely detectable in the majority of Rictorfl/fl Ksp-Cre mice. Conversely, epithelial sodium channel (ENaC) activity was largely preserved, suggesting that the reduced ability to maintain K+ homeostasis is the result of impaired apical K+ conductance and not a reduced electrical driving force for K+ secretion. Thus, these data unravel a vital and nonredundant role of mTORC2 for distal tubular K+ handling.

Authors

Florian Grahammer, Viatcheslav Nesterov, Azaz Ahmed, Frederic Steinhardt, Lukas Sandner, Frederic Arnold, Tomke Cordts, Silvio Negrea, Marko Bertog, Marcus A. Ruegg, Michael N. Hall, Gerd Walz, Christoph Korbmacher, Ferruh Artunc, Tobias B. Huber

×

Figure 3

Extracellular potassium levels regulate mTORC2 expression.

Options: View larger image (or click on image) Download as PowerPoint
Extracellular potassium levels regulate mTORC2 expression.
(A–F) Under p...
(A–F) Under physiological conditions, RICTOR could hardly be detected by immunofluorescence in control renal tissue (green, DBA, A and D; red, RICTOR, B and E; merge, C and F; blue, Hoechst 33342). (G–L) Treatment with the K+-sparing diuretic triamterene led to a dramatic upregulation of RICTOR protein in kidney tubules as well as in the renal interstitium. While Ksp-mediated knockout of RICTOR abolished the signal in tubuli, the prominent staining in the interstitium was maintained (green, DBA, G and J; red, RICTOR, H and K; merge, I and L; blue, Hoechst 33342). White arrows point to DBA-positive tubuli. (M and N) Western blot on control tissue with or without treatment with triamterene confirmed the immunofluorescence results, showing a nearly 20-fold increase in RICTOR protein levels (representative images of n = 3 examined animals per genotype are shown; Student’s t test; ##P < 0.01). Scale bar: 100 μm (A–I); 20 μm (J–L).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts